The Puzzle of Pancreatic Cancer: How Steve Jobs Did Not Beat the Odds—but Nobel Winner Ralph Steinman Did

Despite having the same name, the diseases that killed Apple co-founder Steve Jobs and 2011 Nobel laureate Ralph Steinman are different kinds of cancer. Researchers are looking for new ways to diagnose and treat both















Share on Tumblr

Steve Jobs after pancreatic cancer diagnosis

Months to live or years?: The biological mysteries behind the two types of pancreatic cancer still have scientists searching for answers about why some people live for years with the disease and some survive only a matter of months. Image: WIkimedia Commons/mylerdude

Steve Jobs was a rare case, right down to his death. Announced Wednesday, Jobs's death from "complications of pancreatic cancer" only hints at the vast complexity of the disease to which he succumbed at the age of 56.

Jobs joined recently announced Nobel Prize winner Ralph Steinman, actor Patrick Swayze and football great Gene Upshaw as the latest bold-faced name to die from this aggressive disease—one that even he, with his vast fortune, and Steinman, with his use of experimental immunological treatments, could not forestall indefinitely.

Most pancreatic cancers (53 percent) are diagnosed after they have spread—and those have an exceedingly low survival rate, with just 1.8 percent of patients living for more than five years after diagnosis. (For all types of the cancer, the average five-year survival rate when diagnosed is only slightly higher at 3.3 percent.) So how did Jobs, who was diagnosed in the fall of 2003—and who revealed it publicly in 2004—manage to survive for eight years?

Jobs had a rare form of the cancer, known as neuroendocrine cancer, which grows more slowly and is easier to treat, explains Leonard Saltz, acting chief of the gastrointestinal oncology service at Memorial Sloan-Kettering Cancer Center. "Survival for many years or even decades with endocrine cancer is not surprising." For that type, the sort that Jobs had, "survival is measured in years, as opposed to pancreatic cancer, which is measured in months." 

"When you have a pancreatic neuroendocrine tumor, that is substantially different from pancreatic cancer," Saltz says.

Steinman, on the other hand, did have the type that is usually fatal within a year after diagnosis. "Ralph had the garden variety, poorly differentiated pancreatic cancer," says Sarah Schlesinger, an associate professor of immunology and cell physiology at The Rockefeller University, where she worked with Steinman.

Given the grim prognosis for both these forms of cancer, researchers are hard at work trying to develop better treatments and diagnostics, and to figure out just why one patient might live for eight years—and another for eight months.

Two different kinds
Pancreatic cancer is a rare disease, with about 44,000 new cases diagnosed in the U.S. each year, and a lifetime risk of getting it at about 1.4 percent. The vast majority of those cancers—some 95 percent—are known as adenocarcinomas, the sort that Steinman had. Jobs's form, known as pancreatic neuroendrocrine tumor (pNET), makes up the small fraction of other pancreatic cancer sufferers.

The pancreas itself is essentially two different organs, which means two distinct kinds of tissue—and two very different types of cancer, Saltz points out. The most common kind of pancreatic cancer, the adenocarcinomas, originate in what is known as the exocrine portion of the pancreas. This is the main mass of the organ, which makes digestive enzymes that get shuttled to the gastrointestinal tract via specialized ducts.

"Scattered in that larger organ are thousands of tiny islands," Saltz explains. "These are islands of endocrine tissue," which makes hormones that are secreted into the blood. It was a cancer of these islet cells that Jobs had.

Difficult to diagnose

Pancreatic cancer is so deadly in large part because it is often caught at a very late stage. Unlike lung or colon cancer, it does not create a lot of early symptoms. Saltz said he was hesitant to even list the manifestations (which include upper abdominal pain, weight loss, appetite loss and blood clots) because they are such common complaints that, he noted, everyone would go home and decide by this evening that they had pancreatic cancer.



20 Comments

Add Comment
View
  1. 1. ASHIK 08:02 AM 10/7/11

    Steve jobs is a lucky guy to have survived for such a long time since he was diagnosed back in 2003.

    Reply | Report Abuse | Link to this
  2. 2. strubie 08:42 AM 10/7/11

    I realize that the focus of this article is the difference between two types of pancreatic cancer, but I find it simply amazing that there is no mention of the fact that Steve Jobs' pancreatic cancer was diagnosed early and perhaps early enough that he could have had successful treatment for it (http://articles.sfgate.com/2004-08-03/business/17441322_1_neuroendocrine-tumors-survival-rates-islet). I also find it amazing that there is no mention of the fact that Jobs tried "alternative medicine" for 9 months before being treated with real medicine (http://tech.fortune.cnn.com/2008/06/13/steve-jobs-life-after-the-whipple/). I think that this article could have had a greater impact on the medical education of its readers if there was some mention of the difference between genuine medicine and so called "alternative medicine." Steve Jobs should have lived for a much longer time than he did, but the devastating tragedy is that being skeptical of conventional medicine, he decided to think different.

    Reply | Report Abuse | Link to this
  3. 3. bjnicholls 12:34 PM 10/7/11

    Strubie makes and excellent point. Jobs tried a "naturopath diet" as part of his non-science alternative "treatment". There's no way to know how long Jobs may have lived if he hadn't delayed real treatment by nine months, but it's sad that a man with such a critical mind was so credulous when it came to this life and death decision.

    Reply | Report Abuse | Link to this
  4. 4. EJDwulet 01:47 PM 10/7/11

    Of course this is a circumstantial case pieced together from news reports. Jobs had no symptoms. Insulinomas have symptoms when they are big enough to cause them -- its hypoglycemia, a condition diabetics often experience. Jobs got a "routine" abdominal scan or maybe a full body scan which was popular at the time or whatever it is billionaires do to try to "catch cancer early" and live forever. Who knows? If he had not had the scan, maybe the insulinoma becomes big enough to cause hypoglycemia in his lifetime or maybe it doesn't (its found more often in autopsies than clinically -- (as high as 10%)). IF it wasn't just "routine" and he went for a scan WITH SYMPTOMS -- the situation changes. Any half way decent doctor can put two and two together and tell you you have an insulinoma (NO BIOPSY REQUIRED) and he can send you right to the OR to get cured. When they find something on Jobs scan -- since he had no symptoms and his blood work must have been normal -- not even a hint of low glucose -- they assume he has the more common dangerous form. He himself says he thought he had only months to live. So then they tell him they need to do a BIOPSY to be sure because there are other things it may be although the chances of that were slim. Afterwards he says he cried after the doctors told him it was the very rare but very "curable" form. He didn't even rush into any surgery -- they probably told him it was benign, like 90% of them are. But meanwhile the BIOPSY was doing its dirty work -- inflaming the tumor or already seeding metastasis. By the time he had surgery it may have been too late. BIOPSY induced micrometastasis had already begun or possibly surgery on an inflamed insulinoma is more dangerous than one that isn't. Circumstantial for sure but no doubt men have been sent to jail on lesser circumstantial evidence. With full access to his medical records I think someone would have little trouble getting an involuntary manslaughter conviction in the death of Steve Jobs. Jobs was forced "all in" by those "routine scan" results. -- after that he had no real choice but to keep playing and hope to catch that hole card and get out of the game alive. Instead a "routine" scan began a long medical cascade that ended tragically yesterday. Apparently sometimes you can catch cancer too early. Obama's comments on his passing notwithstanding, I think its more horribly ironic as well as pathetically sad that one of the greatest visionaries of modern technology was himself probably done in by modern technology.

    Reply | Report Abuse | Link to this
  5. 5. elderlybloke in reply to EJDwulet 06:48 PM 10/7/11

    Stone me Mate,
    It's a wonder I am still alive,as I had a Liver Biopsy 49 years ago when I had Hepatitis .
    The Biopsy was apparently , to check on whether I had developed Diabetes .

    Reply | Report Abuse | Link to this
  6. 6. wakeele 09:23 PM 10/7/11

    I like the article and the points made about other key areas of Jobs' battle with cancer, but the typos and inconsistant use of contractions are bothersome. OSD--sorry. It gives me hope for shooting off quick articles for reputable media one day though (I'm awful at proofreading--ADHD too).

    Reply | Report Abuse | Link to this
  7. 7. karlt10 10:54 PM 10/7/11

    A common cause of pancreatic cancer is Hereditary Hemochromatosis, or HHC. No idea of his mother's ancestry, but his father's Middle East origins would make 'The Celtic Curse' an unlikely cause.

    Reply | Report Abuse | Link to this
  8. 8. pinho.pereira 07:44 AM 10/8/11

    For the most common adenocarcinoma pancreatic cancer the best first line anticancer treatment, is no more Gemcitabine (Gemzar), but the regimen FOLFIRINOX, for patients with good clinical condition.

    Reply | Report Abuse | Link to this
  9. 9. LarryW in reply to EJDwulet 11:31 AM 10/9/11

    One statement you may have got wrong. Steve Jobs says in his 2005 Stanford address that it was the doctor who cried -- Jobs was under at the time.

    Your comment was interesting and detailed, but I'm afraid I cannot evaluate it. What is your knowledge and expertise in this area?

    Reply | Report Abuse | Link to this
  10. 10. HubertB 09:08 AM 10/10/11

    Since the pancreatic cancer had spread to the liver, I wonder why they just transplanted a new liver. The main problem was the pancreas. Why didn't they transplant both a pancreas and a liver?

    Reply | Report Abuse | Link to this
  11. 11. alan6302 in reply to EJDwulet 09:10 AM 10/10/11

    I agree that doctors reduced his lifespan. Dr. Mercola claims he chose the wrong doctor. When wealthy patients are killed , doctors are looked at as heroes and receive big payoffs. The doctors should be paid only for success.

    Reply | Report Abuse | Link to this
  12. 12. bonbagay38 03:51 PM 10/10/11

    I tried to contact Steve Jobs by mails and emails (by others, since I don't have his email). My message to him was to have him contact Weimar Institute (www.weimar.org) for his treatment. I tried partly because I knew it would be hard for his cancer to be treated by conventional modern medicine. If he listen to his body in a holistic way, his body may find a way to cure itself. Weimar Institute apply NEWSTART, a lifestyle changing regimen, developed by Seventh Day Adventists.

    While I was reading through the article, I could not feel but all the medical scientists look at human body as if it a machine. Human body embodys energy by which human's biological cells work. The energy can be generated by mind, not just from foods. Weimar Institute receives patients whose doctors have given up treatments. But these patients find new life from the NEWSTART. You may not want to hear it, but, believe or not, it is true. There is a secrete in human body that modern medicine cannot find.

    I am pretty sure Steve did not get my message.

    Reply | Report Abuse | Link to this
  13. 13. JimmyD11 02:03 PM 10/11/11

    There's an integrative cancer treatment center that is raising money for pancreatic research in Steve's honor here http://www.nhwellnesscenters.com/stevejobs/

    The email that started it all is pretty well written.

    Kind of wish the stories were more specific.

    Reply | Report Abuse | Link to this
  14. 14. DeborahCalvert 03:12 AM 10/12/11

    I'm a survivor of a pancreatic mucin producing tumor similiar to Jobs' IPMN, called a Mucinous Cystic Neoplasm, diagnosed in 2005, surgery in early 2006, cancer free since then! But it was close, since it tested positive for CD10 expression, confirming it was precancerous. UCLA doctors said I had 2 weeks - 2 months before it'd have turned to cancer and become a regular adenocarcinoma. God blessed me and I thank Howard A Reber, Professor of Pancreatic Surgery at UCLA for saving my life.
    Deborah Calvert, Newport Beach, California

    Reply | Report Abuse | Link to this
  15. 15. EJDwulet in reply to elderlybloke 01:13 PM 10/13/11

    There's a difference between a biopsy on an organ with tumor or a cancer and a biopsy on an organ not so.

    Reply | Report Abuse | Link to this
  16. 16. EJDwulet in reply to LarryW 01:42 PM 10/13/11

    Regardless of who cried, things like commencement addresses are often self-serving pronouncements and exaggerations. At the time Jobs was making a "seize the day" speech, he considered himself "cured" and as many cancer "survivors" do, he was pinning a ribbon on himself for fighting and beating cancer. My views come from my own research on prostate cancer, the only cancer I know of where they will do a biopsy and then tell you you can watch and wait and where there is ample accumulating evidence that possibly a biopsy and definitely surgery for a tumor with a low metastatic potential, itself, may be an important metastatic mechanism. Here are some plain language references you might begin with Googling : (1) "Old Ideas Spur New Approaches in Cancer Fight." Published: December 28, 2009 If you are watching and waiting read the article before you submit to another biopsy. Some excerpts: "Over and over, doctors and patients tell stories of injuries that seemed to spur a cancer. A blow to the breast, an operation, and suddenly cancer takes off. It may mean nothing, just an effort to explain the seemingly inexplicable. "... mathematical modeling indicates that surgery at the site of a dormant tumor can spur it to grow." "if wounding or inflammation has an effect, it happens only under unusual conditions and if tiny cancers are already present at the site of the wound." "Most likely, if there is an effect, it happens only if tiny cancers are already present at the site of the injury. " "It made her ask about biopsies ... “Frankly, this has not been studied extensively,” Dr. Polyak said. “People don’t like to bring it up.”" (2) From the Economist 12/11/2010: Better safe than sorry Medicine: A new type of needle provides a better way to collect samples from tumours, without the risk of spreading the cancer. (3) “Our findings suggest that promoting inflammation of the cancerous tissue – for instance, by performing prostate biopsies – may, ironically, hasten progression of metastasis,” said Karin. “We have shown that proteins produced by inflammatory cells are the ‘smoking gun’ behind prostate cancer metastasis. The next step is to completely indict one of them.”

    Reply | Report Abuse | Link to this
  17. 17. BuckSkinMan in reply to strubie 04:35 PM 10/13/11

    I think it's absolutely important to highlight Mr. Jobs' decision to first try "alternative medicine" (which is another term for hoax medicine). Steve McQueen is another example of a desperate man who had money and an ego which tricked him into believing he'd found a way to beat the odds which were killing other victims. Both men made their living selling the not-quite real, Jobs was a master salesman and McQueen was a famous actor. It's worth mentioning because facing certain death pressures the victim to seek other kinds of unreality. There're plenty of charlatans out there ready to take your money or your insurer's money. Meanwhile: Science marches slowly but it does keep marching.

    Reply | Report Abuse | Link to this
  18. 18. BuckSkinMan in reply to EJDwulet 04:52 PM 10/13/11

    I'll second your statement about "injuries" triggering cancerous growths. 2 years ago, I (very slightly) scratched an itch under my right eye. That little scrape on the skin didn't heal: it started a growth which, within 2 months proved to be skin cancer. Before scratching: skin clear, after scratching: tumor appears. Three sessions of MOHS surgery removed all traces. Unpleasant but nothing compared to other surgeries.

    BTW: another person I know waited 2 years before having her skin tumor looked at. She's undergone far more surgeries and still the doctors aren't sure she's cancer free. DO NOT WAIT to have suspicious lesions examined!

    I learned also: I have "Celtic heritage" and that, in my 60s, makes me a prime candidate for MORE skin cancers. Whatever remains of my life: I must be on constant watch for any changes on my skin.

    Reply | Report Abuse | Link to this
  19. 19. EJDwulet 12:28 AM 11/10/11

    To update and verify parts of my speculation about Steve Jobs this medical journal report will show that a biopsy is not necessary to diagnosis an insulinoma in someone with SYMPTOMS. Jobs obviously had no symptoms and wanted to find out what the "shadow" was on his CT scan which was done to check for a recurrence of kidney stones. This case study the biopsy, while not causing metastasis, caused significant harm. http://www.contemporarysurgery.com/pages.asp?aid=321 "Is a DiagnosticTissue Biopsy Always a Good Idea?"

    Reply | Report Abuse | Link to this
  20. 20. ironjustice 11:52 AM 6/30/12

    "Celtic heritage"
    Twice , the human model of cancer , the Celtic Curse , was mentioned in this conversation. Neuroendocrine cancer is very common in those with the Celtic Curse , excess iron .
    "Iron overload in the endocrine glands"

    Iron overload in the pancreas.
    "MRI disclosed in 19 of 21 patients moderate to severe IO in the liver and spleen, in three of eight patients in the pancreas"

    Iron chelating drugs are used in different cancers. One might wonder whether the underlying cause of cancer IS , as evidenced by recovery , iron excess ?
    "NOVEL THIOSEMICARBAZONE IRON CHELATORS INDUCE UP-REGULATION AND PHOSPHORYLATION OF THE METASTASIS SUPPRESSOR, NDRG1: A NEW STRATEGY FOR THE TREATMENT OF PANCREATIC CANCER."
    "IRON CHELATORS INDUCE UP-REGULATION AND PHOSPHORYLATION OF THE METASTASIS SUPPRESSOR, NDRG1"
    "Doxorubicin (DOX) up-regulated mRNA levels of the iron-regulated genes transferrin receptor-1 (TfR1) and N-myc downstream-regulated gene-1 (Ndrg1). This effect was mediated by iron depletion, because it was reversed by adding iron and it was prevented by saturating the
    anthracycline metal binding site with iron."
    "Ndrg-1 is up-regulated in cells following iron (Fe)-depletion using Fe chelators"
    "Ndrg-1 expression was demonstrated to be regulated by cellular iron levels and induced by iron chelators."
    "Increased Ndrg1 expression following Fe chelation was related to the permeability and antiproliferative activity of chelators and could be reversed by Fe repletion."





    Reply | Report Abuse | Link to this
Leave this field empty

Add a Comment

You must sign in or register as a ScientificAmerican.com member to submit a comment.
Click one of the buttons below to register using an existing Social Account.

More from Scientific American

See what we're tweeting about

Scientific American Editors

More »

Free Newsletters


Get the best from Scientific American in your inbox

Solve Innovation Challenges

Powered By: Innocentive

  SA Digital

Latest from SA Blog Network

  SA Digital

Email this Article

The Puzzle of Pancreatic Cancer: How Steve Jobs Did Not Beat the Odds—but Nobel Winner Ralph Steinman Did

X
Scientific American Magazine

Subscribe Today

Save 66% off the cover price and get a free gift!

Learn More >>

X

Please Log In

Forgot: Password

X

Account Linking

Welcome, . Do you have an existing ScientificAmerican.com account?

Yes, please link my existing account with for quick, secure access.



Forgot Password?

No, I would like to create a new account with my profile information.

Create Account
X

Report Abuse

Are you sure?

X

Institutional Access

It has been identified that the institution you are trying to access this article from has institutional site license access to Scientific American on nature.com. To access this article in its entirety through site license access, click below.

Site license access
X

Error

X

Share this Article

X